Position in PFE
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$2,309,199
-$399,622 QoQ
Shares Held
95,897
-0.6% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#893
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 37%
Shared 0%
None 63%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CARRET ASSET MANAGEMENT, LLC holds $55,272,630 across 8 Drug Manufacturers - General names. PFE ranks #5 (4.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
80,403 | $20,419,949 | |
| 2 | ABBV |
AbbVie Inc.
|
50,635 | $12,741,791 | |
| 3 | MRK |
Merck & Co., Inc.
|
78,520 | $10,089,820 | |
| 4 | LLY |
ELI LILLY & Co
|
4,753 | $5,700,891 | |
| 5 | PFE |
Pfizer Inc
This page
|
95,897 | $2,309,199 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
39,339 | $2,266,713 | |
| 7 | AMGN |
Amgen Inc
|
3,979 | $1,440,875 | |
| 8 | AZN |
Astrazeneca PLC
|
1,600 | $303,392 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,309,199 | 95,897 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $2,708,821 | 96,468 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $2,454,517 | 98,575 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $2,838,395 | 111,397 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,702,299 | 111,481 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $2,881,968 | 113,732 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $3,016,567 | 113,704 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $3,350,441 | 115,772 | Shares | Sole | 2024-10-24 | |
| 2024-06-30 | $3,344,225 | 119,522 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $3,410,946 | 122,917 | Shares | Sole | 2024-04-19 | |
| 2023-12-31 | $3,205,478 | 111,340 | Shares | Sole | 2024-02-02 | |
| 2023-09-30 | $3,800,419 | 114,574 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $4,258,437 | 116,097 | Shares | Sole | 2023-07-25 | |
| 2023-03-31 | $4,695,019 | 115,074 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $6,321,171 | 123,364 | Shares | Sole | 2023-01-10 | |
| 2022-09-30 | $5,376,484 | 122,863 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,450,934 | 123,039 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $6,383,810 | 123,311 | Shares | Sole | 2022-04-13 | |
| 2021-12-31 | $7,005,337 | 118,634 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $5,033,589 | 117,033 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $4,740,083 | 121,044 | Shares | Sole | 2021-07-14 | |
| 2021-03-31 | $4,498,642 | 124,169 | Shares | Sole | 2021-07-14 | |
| 2020-12-31 | $4,592,967 | 124,775 | Shares | Sole | 2021-03-16 | |
| 2020-09-30 | $4,553,511 | 124,074 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $3,987,899 | 121,954 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $3,900,572 | 119,503 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||